Course Description
Knowledge about the pathogenesis, diagnosis, and management of glomerular diseases is advancing rapidly. In this program, a panel of international experts from this exciting field discusses these advances using lectures, interactive case-based discussions, panel discussions, and more. Participants learn clinical applications as they review updates in treatments, pathology, genetics, and glomerular diseases in special populations.
All presentations will be available on-demand starting one week prior to the program through December 4. This program will feature two live, interactive sessions on October 19-20 which will be available on-demand after the live sessions. Note: There is no syllabus.
ASN designates this blended learning activity for a maximum of 13.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. (The credits total has been updated based on actual time.)
Course Objective(s)
Upon completion of the course, the participant will be able to: 1) describe and integrate the pathology, diagnosis, and therapeutic options for glomerular diseases; 2) integrate information from current basic research studies and clinical trials, and apply it to the diagnosis and management of glomerular disorders; and 3) analyze nuances in the treatment of patients with difficult glomerular diseases.
Topics :
1. APOL1- A Therapeutic Target in Glomerular Disease
2. Complement in C3 Glomerulopathy and Common Kidney Diseases
3. Glomerular Disease in Children
4. Glomerular Disease in Pregnancy
5. Glomerular Diseases- 2020 Update (Live-Stream 1) – ASN Kidney Week 2020 Reimagined
6. Glomerular Diseases- 2020 Update (Live-Stream 2) – ASN Kidney Week 2020 Reimagined
7. IgA Nephropathy
8. Management of ANCA-Associated Vasculitis
9. Management of Dysproteinemias
10. Management of Lupus Nephritis
11. Management of Membranous Nephropathy
12. Management of Minimal Change Disease and FSGS
13. Management of Nephrotic Syndrome
14. Pathology and Classification of C3 Glomerulopathy and Thrombotic Microangiopathy
15. Pathology of Dysproteinemias
16. Pathology of FSGS and Membranous Nephropathy
17. Precision Medicine in Glomerular Disease
18. Update on Diabetic Kidney Disease
Release Date : October 14, 2020
